Advertisement
U.S. markets open in 8 hours 14 minutes

Dynavax Technologies Corporation (DVAX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
11.70-0.35 (-2.90%)
At close: 04:00PM EDT
11.75 +0.05 (+0.43%)
After hours: 06:40PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close12.05
Open11.96
Bid12.71 x 800
Ask12.91 x 4000
Day's Range11.65 - 12.02
52 Week Range9.48 - 15.15
Volume1,803,674
Avg. Volume2,014,980
Market Cap1.528B
Beta (5Y Monthly)1.25
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-19% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for DVAX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Dynavax Technologies Corporatio
    DVAX: Rating decreased to a SELLDYNAVAX TECHNOLOGIES CORP has an Investment Rating of SELL; a target price of $13.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
  • GuruFocus.com

    Chief Accounting Officer Justin Burgess Sells Shares of Dynavax Technologies Corp (DVAX)

    Justin Burgess, the Chief Accounting Officer of Dynavax Technologies Corp (NASDAQ:DVAX), has sold 20,526 shares of the company on March 1, 2024, according to a recent SEC Filing.

  • Insider Monkey

    11 Best Small Cap Pharma Stocks to Invest In

    In this piece, we will take a look at the 11 best small cap pharma stocks to invest in. If you want to skip our overview of the global pharmaceutical and healthcare industry, which is one the most unique sectors in the world, then you can check out 5 Best Small Cap Pharma Stocks to […]

  • Insider Monkey

    Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2023 Earnings Call Transcript

    Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2023 Earnings Call Transcript February 22, 2024 Dynavax Technologies Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day ladies and gentlemen and welcome to the Dynavax Technologies’ Fourth Quarter and Full Year 2023 […]